Editorial Team
The management of our journal is a collaborative endeavor by the whole editorial team, featuring an active, widely respected, diverse, and representative Editorial Board. The editorial structure of the journal is listed as below and the roles and responsibilities of the editorial team are available at: https://www.amegroups.com/pages/journal-management#content-title.
International Advisory Board
Daniel J. Klionsky, AB, PhD
Life Sciences Institute and Department of Molecular, Cellular and Developmental Biology, University of Michigan, Ann Arbor, MI, USA
Executive Editor-in-Chief
Hualin Sun, MD
Jiangsu Key Laboratory of Neuroregeneration, Nantong University, Jiangsu, China
Editorial Board
Mitesh J. Borad, MD
Division of Hematology and Oncology, Mayo Clinic, Scottsdale, AZ, USA
Stefania Bruno, PhD
Department of Medical Sciences, University of Torino, Italy
Joseph Chao, MD
Department of Medical Oncology and Therapeutics Research, City of Hope, Duarte, CA, USA
William C. Cho, PhD, RCMP, FHKIMLS, FHKSMDS, Chartered Scientist (UK), FIBMS (UK)
Queen Elizabeth Hospital, Hong Kong, China
Joanna Domagala-Kulawik, MD
Professor of Medicine, Medical University of Warsaw, Warszawa, Poland
Jimmy Hwang, MD, FACP
Levine Cancer Institute, Carolinas HealthCare System, Charlotte, NC, USA
Patrick C. Ma, MD, MSc
Sara Crile Allen and James Frederick Allen Comprehensive Lung Cancer Program, WVU Cancer Institute, West Virginia University, Morgantown, WV, USA
Giulio Metro, MD
Division of Medical Oncology, Santa Maria della Misericordia Hospital, Azienda Ospedaliera di Perugia, via Dottori, Perugia, Italy
Robson Q. Monteiro, PhD
Laboratory of Thrombosis and Cancer, Institute of Medical Biochemistry, Federal University of Rio de Janeiro (UFRJ), Rio de Janeiro, RJ, Brazil
Giannis Mountzios, MD, MSc, PhD
Department of Medical Oncology, University of Athens School of Medicine, Athens, Greece
Rudolph M. Navari, MD, PhD, FACP
Professor of Medicine, Senior Scientist, Comprehensive Cancer Center, University of Alabama Birmingham School of Medicine, Birmingham, AL, USA
Masahiko Nishiyama, MD, PhD
Department of Molecular Pharmacology & Oncology, Gunma University Graduate School of Medicine, Maebashi, Gunma, Japan
Alain Piché, MD, MSc
Département de Microbiologie et Infectiologie, Université de Sherbrooke, Québec, Canada
Tomasz Powrózek, PhD
Department of Human Physiology, Medical University of Lublin, Poland
Ram Prasad, PhD
Department of Ophthalmology and Visual Sciences, School of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA
Hope S. Rugo, MD
Professor of Medicine, Director, Breast Oncology and Clinical Trials Education, University of California San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco,CA, USA
Giulia M. Stella, MD, PhD
Department of Hematological, Pneumological and Cardiovascular Sciences - Section of Pneumology, University and Fondazione IRCCS Policlinico, Pavia, Italy
Francesco Vasuri, MD, PhD
Pathology Unit, S.Orsola-Malpighi University Hospital, Bologna, Italy
Lou Zhong, MD
Thoracic Surgery, Affiliated Hospital of Nantong University, Jiangsu, China
Jianwei Zhu, MD
Department of Orthopedics, Affiliated Hospital of Nantong University, Jiangsu, China
Science Editors
Jia-ying Bai
Editorial Office, Biotarget
Suki X. Tang
Editorial Office, Biotarget
Amber Yuen
Editorial Office, Biotarget